Stockreport

Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028 [Seeking Alpha]

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF Kenneth Galbraith, Chairman, CEO, Acting CFO & President, opened by highlighting the Phase III HERIZON-GEA-01 trial results: "Zanidatamab in combination with chemothera [Read more]